Literature DB >> 8505855

Differences in expression of monocyte/macrophage surface antigens in peripheral blood and bronchoalveolar lavage cells in interstitial lung diseases.

H C Hoogsteden1, P T van Hal, J M Wijkhuijs, W Hop, C Hilvering.   

Abstract

The surface antigens of monocytic cells in bronchoalveolar lavage (BAL) fluid were analyzed in 10 patients with sarcoidosis, 8 patients with idiopathic pulmonary fibrosis (IPF), 9 patients with extrinsic allergic alveolitis (EAA), and 10 healthy volunteers, and compared with the surface antigens of peripheral blood monocytes (PBM) of the same individuals. The absolute numbers of alveolar macrophages (AM) were increased in all disease groups as were the numbers of small monocyte-like cells, indicating an increased influx of PBM into the alveoli, which was the most prominent in EAA patients. In all groups investigated, the percentages of PBM positive for the monoclonal antibodies (mAb) CD13, CD14, CD33, U26, and Max3 were higher than the percentages of BAL macrophages positive for these markers, while the Max24 marker was equally expressed. In all groups the percentages of AM positive for RFD9 and CD68 were higher than the percentages positive for PBM. The absolute numbers of CD13+ macrophages were increased in IPF and EAA patients, probably due to the increased influx of monocytic cells. The 3 mAb in the CD68 cluster (i.e., Ki-M6, Ki-M7, and Y2/131) demonstrated marked differences in expression on PBM as well as on AM. This is probably because CD68(Ki-M6) recognizes a different epitope than CD68(Ki-M7) and CD68(Y2/131). The latter 2 become increasingly expressed by AM and this is paralleled by an increased CD68(KiM6) expression. The expression of CD68, which is associated with the generation of oxygen radicals during the respiratory burst and increased chemiluminescence, tended to be elevated on PBM and AM of IPF patients, although with a broad range.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8505855     DOI: 10.1007/BF00183944

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  36 in total

1.  Bimodal differentiation prospectives for promyelocytes.

Authors:  H J Radzun; M R Parwaresch; S Bödewadt; C Sundström; K Lennert
Journal:  J Natl Cancer Inst       Date:  1985-08       Impact factor: 13.506

2.  The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors.

Authors:  S M Goyert; E Ferrero; W J Rettig; A K Yenamandra; F Obata; M M Le Beau
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

3.  Ki-M7 monoclonal antibody specific for myelomonocytic cell lineage and macrophages in human.

Authors:  H Kreipe; H J Radzun; M R Parwaresch; A Haislip; M L Hansmann
Journal:  J Histochem Cytochem       Date:  1987-10       Impact factor: 2.479

4.  A monoclonal antibody to LFA-3, the CD2 ligand, specifically immobilizes major histocompatibility complex proteins.

Authors:  B E Bierer; D E Golan; C S Brown; S H Herrmann; S J Burakoff
Journal:  Eur J Immunol       Date:  1989-04       Impact factor: 5.532

5.  Two leukocyte receptors (CD11a/CD18 and CD11b/CD18) mediate transient adhesion to endothelium by binding to different ligands.

Authors:  S K Lo; G A Van Seventer; S M Levin; S D Wright
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

6.  Surface membrane heterogeneity among human mononuclear phagocytes.

Authors:  A Biondi; T H Rossing; J Bennett; R F Todd
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

Review 7.  The alveolitis of hypersensitivity pneumonitis.

Authors:  U Costabel
Journal:  Eur Respir J       Date:  1988-01       Impact factor: 16.671

8.  Human monocyte adherence to cultured vascular endothelium: monoclonal antibody-defined mechanisms.

Authors:  W J Wallis; P G Beatty; H D Ochs; J M Harlan
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

9.  Surface marker analysis of acute myeloblastic leukemia: identification of differentiation-associated phenotypes.

Authors:  J D Griffin; R J Mayer; H J Weinstein; D S Rosenthal; F S Coral; R P Beveridge; S F Schlossman
Journal:  Blood       Date:  1983-09       Impact factor: 22.113

10.  Maintenance of the normal rat alveolar macrophage cell population. The roles of monocyte influx and alveolar macrophage proliferation in situ.

Authors:  J Shellito; C Esparza; C Armstrong
Journal:  Am Rev Respir Dis       Date:  1987-01
View more
  5 in total

Review 1.  Lung fibrosis.

Authors:  C Fonseca; D Abraham; C M Black
Journal:  Springer Semin Immunopathol       Date:  1999

Review 2.  Takes your breath away--the immunology of allergic alveolitis.

Authors:  C McSharry; K Anderson; S J Bourke; G Boyd
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

3.  Localization of surfactant protein A (SP-A) in alveolar macrophage subpopulations of normal and fibrotic rat lung.

Authors:  M Kasper; K Sakai; R Koslowski; K W Wenzel; G Haroske; D Schuh; M Müller
Journal:  Histochemistry       Date:  1994-11

4.  Peptidases in human bronchoalveolar lining fluid, macrophages, and epithelial cells: dipeptidyl (amino)peptidase IV, aminopeptidase N, and dipeptidyl (carboxy)peptidase (angiotensin-converting enzyme).

Authors:  L Juillerat-Jeanneret; J D Aubert; P Leuenberger
Journal:  J Lab Clin Med       Date:  1997-12

5.  Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline.

Authors:  Ganesh Raghu; Martine Remy-Jardin; Christopher J Ryerson; Jeffrey L Myers; Michael Kreuter; Martina Vasakova; Elena Bargagli; Jonathan H Chung; Bridget F Collins; Elisabeth Bendstrup; Hassan A Chami; Abigail T Chua; Tamera J Corte; Jean-Charles Dalphin; Sonye K Danoff; Javier Diaz-Mendoza; Abhijit Duggal; Ryoko Egashira; Thomas Ewing; Mridu Gulati; Yoshikazu Inoue; Alex R Jenkins; Kerri A Johannson; Takeshi Johkoh; Maximiliano Tamae-Kakazu; Masanori Kitaichi; Shandra L Knight; Dirk Koschel; David J Lederer; Yolanda Mageto; Lisa A Maier; Carlos Matiz; Ferran Morell; Andrew G Nicholson; Setu Patolia; Carlos A Pereira; Elisabetta A Renzoni; Margaret L Salisbury; Moises Selman; Simon L F Walsh; Wim A Wuyts; Kevin C Wilson
Journal:  Am J Respir Crit Care Med       Date:  2020-08-01       Impact factor: 30.528

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.